查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1579661

全球静脉支架市场

Venous Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球静脉支架市场将达21亿美元

2023年全球静脉支架市场预计为12亿美元，预计到2030年将达21亿美元，2023-2030年分析期间复合年增长率为8.4%。髂静脉支架技术是本报告分析的细分市场之一，预计复合年增长率为 8.3%，到分析期结束时将达到 14 亿美元。在分析期间，墙壁支架技术领域的复合年增长率预计为 8.5%。

美国市场预估价值3.19亿美元，中国预期复合年增长率11.2%

预计2023年美国静脉支架市场规模将达3.19亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 4.745 亿美元，2023-2030 年分析期间复合年增长率为 11.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.5% 和 6.7%。在欧洲，德国的复合年增长率预计约为 6.5%。

全球静脉支架市场 – 探索主要趋势和市场驱动因素

为什么静脉支架在血管疾病治疗上变得越来越重要？

静脉支架已成为治疗慢性静脉疾病的重要工具，为静脉闭塞、深层静脉栓塞症（DVT）和其他血管疾病患者提供微创解决方案。但为什么这些设备对于现代血管治疗至关重要？静脉支架是一种小的网状金属管，插入静脉中可恢復正常的血流并防止静脉塌陷或阻塞。此支架专门用于解决静脉功能不全的问题，静脉功能不全是指静脉无法有效地将血液从腿部回流至心臟，导致疼痛、肿胀和静脉曲张等症状。与用于处理高压血流的动脉支架不同，静脉支架针对血压较低和不同结构特征的静脉进行了优化。其设计确保了灵活性和与血管壁的贴合性，使其在保持静脉通畅性和缓解与静脉闭塞相关的症状方面非常有效。

慢性静脉疾病的盛行率不断上升，推动了对静脉支架的需求，这种疾病影响着全世界数百万人，如果不及时治疗，可能会导致严重的併发症。压迫疗法和抗凝血剂等传统治疗方法通常不足以治疗晚期静脉闭塞，因此置入术成为首选治疗方法。静脉支架透过物理方式打开狭窄或闭塞的静脉，改善血流并降低腿部溃疡和血栓症復发等併发症的风险，提供了长期解决方案。静脉支架在治疗血栓后症候群（PTS）和髂静脉压迫症候群（May-Thurner 症候群）等疾病中特别普遍，支架置入术已被证明可显着改善患者的预后和生活品质。随着人们对静脉疾病和支架置入术益处的认识不断提高，医疗保健提供者越来越多地选择静脉支架作为复杂静脉病变的首选。

科技创新如何提高静脉支架的有效性？

静脉支架市场见证了显着的技术进步，提高了这些设备的安全性、有效性和耐用性。但推动这些发展的关键技术创新是什么？最显着的进步之一是静脉专用支架的开发，该支架解决了静脉独特的解剖学和生理学挑战。传统支架最初是为动脉设计的，但由于静脉的动态特性不同，在静脉环境中使用时往往效果不佳。为此，製造商正在行销静脉专用支架，其具有柔韧性、径向力以及抗扭结和抗压缩等特性。这些支架的设计符合静脉解剖结构，即使在曲折或高度弯曲的血管中，也能确保长期通畅性并防止迁移或断裂，从而最大限度地降低风险。此外，在支架结构中使用镍钛诺和钴铬合金提高了其强度和弹性，使其适用于大直径静脉和高压缩部位。

另一项重要的创新是药物洗脱支架的引入。支架涂有药物，可防止组织过度生长并降低支架内血管再阻塞的风险。这项技术已经在动脉支架中取得了成功，在静脉支架中也显示出了前景，因为血管再阻塞的风险是静脉支架的关键问题。药物释放型支架随着时间的推移释放抗增殖药物，以抑制支架内疤痕组织的生长并保持管腔通畅性。此外，血管内超音波（IVUS）和数位减影血管造影术（DSA）等影像技术的进步提高了支架放置的准确性，可以更准确地评估静脉形态并确保支架处于最佳位置。这些技术的整合不仅提高了静脉支架的安全性和有效性，而且扩大了其在更复杂病例中的应用，例如多阶段静脉闭塞和復发性 DVT。因此，静脉支架显着提高了其针对多种静脉疾病的有效性，并且越来越多地在临床实践中被采用。

哪些市场趋势正在推动静脉支架在血管治疗的应用？

静脉支架在血管治疗中的采用是由几个新兴市场趋势推动的，这些趋势反映了患者和医疗保健提供者不断变化的需求。最显着的趋势之一是对微创手术的日益关注。我们看到静脉疾病向血管内治疗的强烈转变，因为患者和临床医生优先考虑更快的恢復时间、更低的併发症发生率和更短的住院时间。静脉置入术是一种微创选择，比传统的开放性手术创伤更小，使其成为治疗慢性静脉功能不全和静脉闭塞的首选。这种趋势在已开发地区尤其明显，这些地区先进的医疗基础设施和意识层级支持微创手术的广泛采用。向门诊手术的转变也推动了对静脉支架的需求。这些设备通常可以在当天植入，从而最大限度地减少对患者日常生活的干扰。

推动静脉支架采用的另一个重要趋势是人们越来越认识到慢性静脉疾病是一个主要的公共卫生问题。由于世界人口老化以及肥胖、久坐生活方式和长期不动等危险因子的增加，静脉疾病的盛行率正在上升。这提高了医疗保健提供者和患者对早期诊断和早期疗育重要性的认识。因此，人们越来越重视在静脉闭塞导致静脉溃疡和肺动脉栓塞等严重併发症之前对其进行筛检和治疗。临床指引和共识声明的发布进一步支持了静脉支架的采用，强调了置入术在静脉疾病治疗中的作用。这些指南由主要血管学会发布，阐明了患者选择、手术和术后管理，并促进静脉支架在临床实践中的广泛使用和标准化。这些趋势反映了静脉疾病朝向更积极、更有效的管理方向的更广泛转变，并将静脉支架定位为现代血管治疗策略的基石。

推动全球静脉支架市场成长的因素有哪些？

全球静脉支架市场的成长受到多种因素的推动，例如支架技术的进步、静脉疾病盛行率的增加以及对微创手术的需求不断增长。主要成长要素之一是静脉支架在复杂静脉病理（如 PTS 和髂静脉压迫）治疗中的广泛使用。随着人们对这些疾病认识的提高和诊断能力的提高，越来越多的患者适合接受置入术，从而导致对静脉支架的需求增加。专为解决静脉解剖挑战而设计的静脉支架专用设备的出现也有助于市场成长，因为与传统支架相比，它们提供了更出色的临床效果。具有更高灵活性、径向强度和抗压缩性的下一代支架的开发将进一步扩大可以从静脉置入术术中受益的患者范围，包括原发性和復发性静脉闭塞病例。

另一个主要成长要素是医疗设备製造商加大研发投资。随着竞争的加剧，製造商专注于开发具有改进设计和先进涂层的创新静脉支架，以满足患者和临床医生未满足的需求。临床试验和研究证明了这些新型支架的长期安全性和有效性，有助于建立医疗保健专业人员的信心，并推动这些设备在临床实践中的广泛使用。此外，慢性静脉疾病的负担日益增加，尤其是老年族群，增加了对更有效治疗方案的需求。随着世界人口老化，静脉疾病的盛行率预计将增加，进一步增加静脉支架的需求。随着支持性的保险报销政策和人们对置入术临床益处的日益认识，在技术创新、临床采用和人口趋势的动态相互作用的推动下，全球静脉支架市场有望持续增长。

受访企业范例（43家知名企业）

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP16887

Global Venous Stents Market to Reach US$2.1 Billion by 2030

The global market for Venous Stents estimated at US$1.2 Billion in the year 2023, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Iliac Vein Stent Technology, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Wallstent Technology segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.0 Million While China is Forecast to Grow at 11.2% CAGR

The Venous Stents market in the U.S. is estimated at US$319.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$474.5 Million by the year 2030 trailing a CAGR of 11.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Venous Stents Market - Key Trends & Growth Drivers Explored

Why Are Venous Stents Gaining Importance in Vascular Disease Management?

Venous stents have emerged as a crucial tool in the management of chronic venous diseases, offering a minimally invasive solution for patients suffering from venous obstructions, deep vein thrombosis (DVT), and other vascular conditions. But what makes these devices so essential in modern vascular care? Venous stents are small, mesh-like metal tubes inserted into veins to restore proper blood flow and prevent vein collapse or blockage. They are specifically designed to address venous insufficiencies, a condition where veins are unable to effectively return blood from the lower extremities back to the heart, causing symptoms like pain, swelling, and varicose veins. Unlike arterial stents, which are used in arteries that handle high-pressure blood flow, venous stents are optimized for veins with lower blood pressure and different structural characteristics. Their design ensures flexibility and conformity to the vessel wall, making them highly effective for maintaining vein patency and alleviating symptoms associated with venous obstruction.

The demand for venous stents is driven by the increasing prevalence of chronic venous disorders, which affect millions of people worldwide and can lead to severe complications if left untreated. Traditional treatment options, such as compression therapy and anticoagulant medication, often fall short in managing advanced cases of venous obstruction, making stenting a preferred therapeutic option. Venous stents offer a long-lasting solution by physically opening narrowed or blocked veins, thereby improving blood flow and reducing the risk of complications like leg ulcers and recurrent thrombosis. The adoption of venous stents is particularly prevalent in the treatment of conditions such as post-thrombotic syndrome (PTS) and iliac vein compression syndrome (May-Thurner syndrome), where stenting has been shown to significantly improve patient outcomes and quality of life. As awareness of venous diseases and the benefits of stenting continues to grow, healthcare providers are increasingly opting for venous stents as a first-line intervention for complex venous pathologies.

How Are Technological Innovations Enhancing the Effectiveness of Venous Stents?

The venous stents market has witnessed significant technological advancements that have improved the safety, efficacy, and durability of these devices. But what are the key innovations driving these developments? One of the most notable advancements is the development of dedicated venous stent designs that address the unique anatomical and physiological challenges of veins. Traditional stents, initially designed for arterial applications, often struggled to provide optimal outcomes when used in venous settings due to the different biomechanical properties of veins. In response, manufacturers have introduced venous-specific stents with features such as greater flexibility, radial force, and resistance to kinking and compression. These stents are engineered to conform to the venous anatomy, even in tortuous or highly curved vessels, ensuring long-term patency and minimizing the risk of migration or fracture. Additionally, the use of nitinol and cobalt-chromium alloys in stent construction has enhanced their strength and elasticity, making them better suited for large-diameter veins and high-compression areas.

Another critical innovation is the introduction of drug-eluting venous stents, which are coated with pharmacological agents that prevent excessive tissue growth and reduce the risk of in-stent restenosis. This technology, already successful in arterial stents, has shown promise in venous applications, where the risk of restenosis is a significant concern. Drug-eluting stents release anti-proliferative drugs over time, inhibiting the growth of scar tissue within the stent and maintaining lumen patency. Moreover, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and digital subtraction angiography (DSA), have enhanced the precision of stent placement, allowing for more accurate assessment of vein morphology and ensuring that the stent is optimally positioned. The integration of these technologies has not only improved the safety and efficacy of venous stents but has also expanded their use in more complex cases, such as multi-level venous obstructions and recurrent DVT. As a result, the effectiveness of venous stents in treating a broader range of venous diseases has been significantly enhanced, driving their adoption in clinical practice.

What Market Trends Are Driving the Adoption of Venous Stents in Vascular Treatment?

Several emerging market trends are shaping the adoption of venous stents in vascular treatment, reflecting the evolving needs of both patients and healthcare providers. One of the most prominent trends is the increasing focus on minimally invasive procedures. As patients and clinicians prioritize faster recovery times, lower complication rates, and reduced hospital stays, there has been a strong shift towards endovascular treatments for venous diseases. Venous stenting, as a minimally invasive option, offers a less traumatic alternative to traditional open surgery, making it a preferred choice for managing chronic venous insufficiency and venous obstructions. This trend is particularly evident in developed regions, where advanced healthcare infrastructure and high patient awareness levels support the widespread adoption of minimally invasive techniques. The shift towards outpatient procedures has also driven the demand for venous stents, as these devices can often be implanted in a same-day setting, minimizing disruption to patients’ daily lives.

Another significant trend driving the adoption of venous stents is the growing recognition of chronic venous disorders as a major public health issue. With an aging global population and rising incidence of risk factors such as obesity, sedentary lifestyles, and prolonged immobility, the prevalence of venous diseases is on the rise. This has led to increased awareness among healthcare providers and patients about the importance of early diagnosis and intervention. As a result, there is a growing emphasis on screening and treating venous obstructions before they lead to more severe complications, such as venous ulcers or pulmonary embolism. The adoption of venous stents has been further supported by the publication of clinical guidelines and consensus statements that highlight the role of stenting in managing venous diseases. These guidelines, issued by leading vascular societies, have provided clarity on patient selection, procedural techniques, and post-procedure management, facilitating more widespread and standardized use of venous stents across clinical settings. These trends reflect a broader shift towards more proactive and effective management of venous diseases, positioning venous stents as a cornerstone of modern vascular treatment strategies.

What Factors Are Driving the Growth of the Global Venous Stents Market?

The growth in the global venous stents market is driven by several factors, including advancements in stent technology, increasing prevalence of venous disorders, and the rising demand for minimally invasive procedures. One of the primary growth drivers is the expanding use of venous stents in the treatment of complex venous pathologies, such as PTS and iliac vein compression. As awareness of these conditions grows and diagnostic capabilities improve, more patients are being identified as candidates for stenting, leading to increased demand for venous stents. The availability of dedicated venous stents that are specifically designed to address the challenges of venous anatomy has also contributed to market growth, as these devices offer better clinical outcomes compared to traditional stents. The development of next-generation stents with enhanced flexibility, radial strength, and resistance to compression has further expanded the range of patients who can benefit from venous stenting, driving adoption in both primary and recurrent cases of venous obstruction.

Another key growth driver is the increasing investment in research and development by medical device companies. As competition intensifies, manufacturers are focusing on developing innovative venous stents with improved designs and advanced coatings to address the unmet needs of patients and clinicians. Clinical trials and studies demonstrating the long-term safety and efficacy of these new stents are helping to build confidence among healthcare providers, encouraging more widespread use of these devices in clinical practice. Additionally, the rising burden of chronic venous diseases, particularly in aging populations, is creating a need for more effective treatment options. The prevalence of venous disorders is expected to increase as the global population ages, further fueling demand for venous stents. With supportive reimbursement policies and the growing recognition of the clinical benefits of stenting, the global venous stents market is poised for sustained growth, driven by a dynamic interplay of technological innovation, clinical adoption, and demographic trends.

Select Competitors (Total 43 Featured) -

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Venous Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Venous Insufficiency and Deep Vein Thrombosis Drives Demand for Venous Stents
    • Increased Adoption of Minimally Invasive Vascular Procedures Expands Addressable Market for Venous Stents
    • Surge in Demand for Venous Stents in Post-Thrombotic Syndrome Treatment Fuels Market Growth
    • Rising Adoption of Venous Stents in Outpatient and Ambulatory Surgical Centers Sets the Stage for Market Growth
    • Surge in Use of Venous Stents for Treating Pelvic and Iliac Vein Compression Expands Market Opportunities
    • Technological Innovations in Drug-Eluting and Bioabsorbable Venous Stents Propel Market Growth
    • Rising Utilization of Venous Stents in Cancer and Post-Surgical Complications Fuels Market Demand
    • Surge in Adoption of Venous Stents in Pediatric and Geriatric Venous Disorders Expands Market Opportunities
    • Technological Advancements in Imaging and Navigation Systems for Venous Stenting Propel Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Venous Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Iliac Vein Stent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Wallstent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Leg by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Chest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Abdomen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Arm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Chronic Deep Vein Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Post Thrombotic Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for May-Thurner Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hemodialysis/Arteriovenous Fistulae by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • JAPAN
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • CHINA
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • EUROPE
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Venous Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • FRANCE
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • GERMANY
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Venous Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • INDIA
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Venous Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Venous Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
  • AFRICA
    • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030

IV. COMPETITION